BG Medicine sets IPO range

BG Medicine Inc. (Waltham, Mass.) amended its IPO and now hopes to sell 4.8 million shares at $13-$15. A $14 price would raise $66.5 million and value the company at $248 million. The offering is underwritten by UBS; Lazard; Baird; and Cowen. BG refiled in January to raise up to $86.3 million. ...